Citations (51)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Peter Davies & Jeremy Koppel. (2009) Mechanism-based treatments for Alzheimer's disease. Dialogues in Clinical Neuroscience 11:2, pages 159-169.
Read now
Read now
Articles from other publishers (50)
Carlo Abbate. (2023) The Adult Neurogenesis Theory of Alzheimer’s Disease. Journal of Alzheimer's Disease 93:4, pages 1237-1276.
Crossref
Crossref
Rayane Hedna, Hervé Kovacic, Alessandra Pagano, Vincent Peyrot, Maxime Robin, François Devred & Gilles Breuzard. (2022) Tau Protein as Therapeutic Target for Cancer? Focus on Glioblastoma. Cancers 14:21, pages 5386.
Crossref
Crossref
Przemysław Czeleń, Agnieszka Skotnicka & Beata Szefler. (2022) Designing and Synthesis of New Isatin Derivatives as Potential CDK2 Inhibitors. International Journal of Molecular Sciences 23:14, pages 8046.
Crossref
Crossref
Yu. A. Sorokina, A. A. Mosina, Yu. M. Pakhomova & A. V. Zanozin. (2022) Biomedical and Potential Therapeutic Aspects of Lithium Carbonate Use. Psikhiatriya 20:2, pages 109-116.
Crossref
Crossref
Weiping Lyu, Qihang Li, Qi Li, Ying Chen, Yingming Wang, Tongzhong Tang, Feng Feng, Heng Chi, Yuan Li, Wenyuan Liu & Haopeng Sun. (2021) Design, Bio‐evaluation and Molecular Dynamics Simulation of Novel GSK‐3β Inhibitors. Molecular Informatics 40:12, pages 2060031.
Crossref
Crossref
Guilherme M. Silva, Rosivaldo S. Borges, Kelton L. B. Santos, Leonardo B. Federico, Isaque A. G. Francischini, Suzane Q. Gomes, Mariana P. Barcelos, Rai C. Silva, Cleydson B. R. Santos & Carlos H. T. P. Silva. (2021) Revisiting the Proposition of Binding Pockets and Bioactive Poses for GSK-3β Allosteric Modulators Addressed to Neurodegenerative Diseases. International Journal of Molecular Sciences 22:15, pages 8252.
Crossref
Crossref
Hamid Reza Moradi, Vahid Hajali, Zabihollah Khaksar, Farzaneh Vafaee, Fatemeh Forouzanfar & Sajad Sahab Negah. (2021) The next step of neurogenesis in the context of Alzheimer’s disease. Molecular Biology Reports 48:7, pages 5647-5660.
Crossref
Crossref
Przemysław Czeleń & Beata Szefler. (2021) The Oxindole Derivatives, New Promising GSK-3β Inhibitors as One of the Potential Treatments for Alzheimer’s Disease—A Molecular Dynamics Approach. Biology 10:4, pages 332.
Crossref
Crossref
Zhiquan Li & Lene Juel Rasmussen. (2020) TIP60 in aging and neurodegeneration. Ageing Research Reviews 64, pages 101195.
Crossref
Crossref
Elisabetta Lauretti, Ozlem Dincer & Domenico Praticò. (2020) Glycogen synthase kinase-3 signaling in Alzheimer's disease. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1867:5, pages 118664.
Crossref
Crossref
Menizibeya O. Welcome. (2020) Neuroinflammation in CNS diseases: Molecular mechanisms and the therapeutic potential of plant derived bioactive molecules. PharmaNutrition 11, pages 100176.
Crossref
Crossref
Carmen Laura Sayas. 2020. Neuroprotection in Autism, Schizophrenia and Alzheimer's Disease. Neuroprotection in Autism, Schizophrenia and Alzheimer's Disease
245
272
.
Preeti Dohare, Ali Kidwai, Japneet Kaur, Pranav Singla, Sachi Krishna, Damon Klebe, Xinmu Zhang, Robert Hevner & Praveen Ballabh. (2019) GSK3β Inhibition Restores Impaired Neurogenesis in Preterm Neonates With Intraventricular Hemorrhage. Cerebral Cortex 29:8, pages 3482-3495.
Crossref
Crossref
Max Holzer, Nico Schade, Ansgar Opitz, Isabel Hilbrich, Jens Stieler, Tim Vogel, Valentina Neukel, Moritz Oberstadt, Frank Totzke, Christoph Schächtele, Wolfgang Sippl & Andreas Hilgeroth. (2018) Novel Protein Kinase Inhibitors Related to Tau Pathology Modulate Tau Protein-Self Interaction Using a Luciferase Complementation Assay. Molecules 23:9, pages 2335.
Crossref
Crossref
Catia M. Teixeira, Noemí Pallas-Bazarra, Marta Bolós, Julia Terreros-Roncal, Jesús Ávila & María Llorens-Martín. (2018) Untold New Beginnings: Adult Hippocampal Neurogenesis and Alzheimer’s Disease. Journal of Alzheimer's Disease 64:s1, pages S497-S505.
Crossref
Crossref
Christiane M. Nday, Despoina Eleftheriadou & Graham Jackson. (2018) Shared pathological pathways of Alzheimer's disease with specific comorbidities: current perspectives and interventions. Journal of Neurochemistry 144:4, pages 360-389.
Crossref
Crossref
Taiki Shimizu, Chiyoko Uchida, Ritsuko Shimizu, Hozumi Motohashi & Takafumi Uchida. (2017) Prolyl isomerase Pin1 promotes proplatelet formation of megakaryocytes via tau. Biochemical and Biophysical Research Communications 493:2, pages 946-951.
Crossref
Crossref
Yuewen Tang & Lin Cheng. (2017) Cocktail of chemical compounds robustly promoting cell reprogramming protects liver against acute injury. Protein & Cell 8:4, pages 273-283.
Crossref
Crossref
Mehdi Sheykhan, Maryam Shafiee-Pour & Masoumeh Abbasnia. (2017)
C–H Activation under the Guise of Diels–Alder Reaction: Annulation toward the Synthesis of Benzo[
e
]isoindole-1,3-diones
. Organic Letters 19:6, pages 1270-1273.
Crossref
Crossref
Teresa Neri-Gómez, Judith Espinosa-Raya, Sofía Díaz-Cintra, Julia Segura-Uribe, Sandra Orozco-Suárez, JuanManuel Gallardo & Christian Guerra-Araiza. (2017) Tibolone modulates neuronal plasticity through regulating Tau, GSK3β/Akt/PI3K pathway and CDK5 p35/p25 complexes in the hippocampus of aged male mice. Neural Regeneration Research 12:4, pages 588.
Crossref
Crossref
Howard Friel & Sally Frautschy. 2017. A Paradigm Shift to Prevent and Treat Alzheimer's Disease. A Paradigm Shift to Prevent and Treat Alzheimer's Disease
151
224
.
Pradip K. Kamat, Anuradha Kalani, Shivika Rai, Santosh Kumar Tota, Ashok Kumar & Abdullah S. Ahmad. (2015) Streptozotocin Intracerebroventricular-Induced Neurotoxicity and Brain Insulin Resistance: a Therapeutic Intervention for Treatment of Sporadic Alzheimer’s Disease (sAD)-Like Pathology. Molecular Neurobiology 53:7, pages 4548-4562.
Crossref
Crossref
Liqin Qi, Linfang Ke, Xiaohong Liu, Lianming Liao, Sujie Ke, Xiaoying Liu, Yanping Wang, Xiaowei Lin, Yu Zhou, Lijuan Wu, Zhou Chen & Libin Liu. (2016) Subcutaneous administration of liraglutide ameliorates learning and memory impairment by modulating tau hyperphosphorylation via the glycogen synthase kinase-3β pathway in an amyloid β protein induced alzheimer disease mouse model. European Journal of Pharmacology 783, pages 23-32.
Crossref
Crossref
Carol A. Lazzara & Yong-Hwan Kim. (2015) Potential application of lithium in Parkinson's and other neurodegenerative diseases. Frontiers in Neuroscience 9.
Crossref
Crossref
Tiago Silva, Joana Reis, José Teixeira & Fernanda Borges. (2014) Alzheimer's disease, enzyme targets and drug discovery struggles: From natural products to drug prototypes. Ageing Research Reviews 15, pages 116-145.
Crossref
Crossref
Eun Bum Kang & Joon Yong Cho. (2014) Effects of treadmill exercise on brain insulin signaling and β-amyloid in intracerebroventricular streptozotocin induced-memory impairment in rats. Journal of Exercise Nutrition and Biochemistry 18:1, pages 89-96.
Crossref
Crossref
Adam J. Smith, Seol-Hee Kim, Naga K. Duggirala, Jingji Jin, Lukasz Wojtas, Jared Ehrhart, Brian Giunta, Jun Tan, Michael J. Zaworotko & R. Douglas Shytle. (2013) Improving Lithium Therapeutics by Crystal Engineering of Novel Ionic Cocrystals. Molecular Pharmaceutics 10:12, pages 4728-4738.
Crossref
Crossref
Lingling Zhang, LinHong Huang, Liangwei Chen, Dingjun Hao & Jianzong Chen. (2013) Neuroprotection by tetrahydroxystilbene glucoside in the MPTP mouse model of Parkinson's disease. Toxicology Letters 222:2, pages 155-163.
Crossref
Crossref
Ulrika Yngve, Peter Söderman, Mats Svensson, Susanne Rosqvist & Per I. Arvidsson. (2012) Imidazopyridine-Based Inhibitors of Glycogen Synthase Kinase 3: Synthesis and Evaluation of Amide Isostere Replacements of the Carboxamide Scaffold. Chemistry & Biodiversity 9:11, pages 2442-2452.
Crossref
Crossref
Xiao-Jing Sun, Lei Zhao, Na Zhao, Xiao-Li Pan, Guo-Qiang Fei, Li-Rong Jin & Chun-Jiu Zhong. (2012) Benfotiamine prevents increased β-amyloid production in HEK cells induced by high glucose. Neuroscience Bulletin 28:5, pages 561-566.
Crossref
Crossref
Nicholas M. Kanaan, Gerardo Morfini, Gustavo Pigino, Nichole E. LaPointe, Athena Andreadis, Yuyu Song, Ellen Leitman, Lester I. Binder & Scott T. Brady. (2012) Phosphorylation in the amino terminus of tau prevents inhibition of anterograde axonal transport. Neurobiology of Aging 33:4, pages 826.e15-826.e30.
Crossref
Crossref
Keith M. Jacobs, Sandeep R. Bhave, Daniel J. Ferraro, Jerry J. Jaboin, Dennis E. Hallahan & Dinesh Thotala. (2012) GSK-3: A Bifunctional Role in Cell Death Pathways. International Journal of Cell Biology 2012, pages 1-11.
Crossref
Crossref
M Cuadrado-Tejedor, I Hervias, A Ricobaraza, E Puerta, JM Pérez-Roldán, C García-Barroso, R Franco, N Aguirre & A García-Osta. (2011) Sildenafil restores cognitive function without affecting β-amyloid burden in a mouse model of Alzheimer's disease. British Journal of Pharmacology 164:8, pages 2029-2041.
Crossref
Crossref
Ying Liu, Fei Liu, Inge Grundke-Iqbal, Khalid Iqbal & Cheng-Xin Gong. (2011) Deficient brain insulin signalling pathway in Alzheimer's disease and diabetes. The Journal of Pathology 225:1, pages 54-62.
Crossref
Crossref
Alejandro López-Tobón, John Fredy Castro-Álvarez, Diego Piedrahita, Ryan L. Boudreau, Juan Carlos Gallego-Gómez & Gloria Patricia Cardona-Gómez. (2011) Silencing of CDK5 as potential therapy for Alzheimer’s disease. revneuro 22:2, pages 143-152.
Crossref
Crossref
Karen Coffman, Michael Brodney, James Cook, Lorraine Lanyon, Jayvardhan Pandit, Subas Sakya, Joel Schachter, Elaine Tseng-Lovering & Matthew Wessel. (2011) 6-Amino-4-(pyrimidin-4-yl)pyridones: Novel glycogen synthase kinase-3β inhibitors. Bioorganic & Medicinal Chemistry Letters 21:5, pages 1429-1433.
Crossref
Crossref
Cheng-Xin Gong, Inge Grundke-Iqbal & Khalid Iqbal. (2010) Targeting Tau Protein in Alzheimerʼs Disease. Drugs & Aging 27:5, pages 351-365.
Crossref
Crossref
Matthew A. Wozniak & Ruth F. Itzhaki. (2010) Antiviral agents in Alzheimer’s disease: hope for the future?. Therapeutic Advances in Neurological Disorders 3:3, pages 141-152.
Crossref
Crossref
Haixia Zou, Liyan Zhou, Yuanzhen Li, Yi Cui, Hanbing Zhong, Zhengying Pan, Zhen Yang & Junmin Quan. (2009)
Benzo[
e
]isoindole-1,3-diones as Potential Inhibitors of Glycogen Synthase Kinase-3 (GSK-3). Synthesis, Kinase Inhibitory Activity, Zebrafish Phenotype, and Modeling of Binding Mode
. Journal of Medicinal Chemistry 53:3, pages 994-1003.
Crossref
Crossref
Thorsten Koechling, Filip Lim, Felix Hernandez & Jesus Avila. (2010) Neuronal Models for Studying Tau Pathology. International Journal of Alzheimer's Disease 2010, pages 1-11.
Crossref
Crossref
Chiara Terracciano, Anna Nogalska, W. King Engel & Valerie Askanas. (2009) In AβPP‐overexpressing cultured human muscle fibers proteasome inhibition enhances phosphorylation of AβPP751 and GSK3β activation: effects mitigated by lithium and apparently relevant to sporadic inclusion‐body myositis. Journal of Neurochemistry 112:2, pages 389-396.
Crossref
Crossref
Antoni Camins, Ester Verdaguer, Felix Junyent, Marc Yeste-Velasco, Carme Pelegrí, Jordi Vilaplana & Mercé Pallás. (2009) Potential Mechanisms Involved in the Prevention of Neurodegenerative Diseases by Lithium. CNS Neuroscience & Therapeutics 15:4, pages 333-344.
Crossref
Crossref
Francesco Panza, Vincenzo Solfrizzi, Vincenza Frisardi, Bruno P. Imbimbo, Cristiano Capurso, Alessia D’Introno, Anna M. Colacicco, Davide Seripa, Gianluigi Vendemiale, Antonio Capurso & Alberto Pilotto. (2013) Beyond the neurotransmitter-focused approach in treating Alzheimer’s Disease: drugs targeting β-amyloid and tau protein. Aging Clinical and Experimental Research 21:6, pages 386-406.
Crossref
Crossref
Javier G. Pizarro, Jaume Folch, José Luis Esparza, J. Jordan, Mercè Pallàs & Antoni Camins. (2009) A molecular study of pathways involved in the inhibition of cell proliferation in neuroblastoma B65 cells by the GSK-3 inhibitors lithium and SB-415286. Journal of Cellular and Molecular Medicine 13:9b, pages 3906-3917.
Crossref
Crossref
Agnès Petit-Paitel, Frédéric Brau, Julie Cazareth & Joëlle Chabry. (2009) Involvment of Cytosolic and Mitochondrial GSK-3β in Mitochondrial Dysfunction and Neuronal Cell Death of MPTP/MPP+-Treated Neurons. PLoS ONE 4:5, pages e5491.
Crossref
Crossref
Ludovico MinatiTrudi Edginton, Maria Grazia Bruzzone & Giorgio Giaccone. (2009) Reviews: Current Concepts in Alzheimer's Disease: A Multidisciplinary Review. American Journal of Alzheimer's Disease & Other Dementiasr 24:2, pages 95-121.
Crossref
Crossref
Paloma Goñi-Oliver, Jesús Avila & Félix Hernández. (2009) Calpain-mediated truncation of GSK-3 in post-mortem brain samples. Journal of Neuroscience Research 87:5, pages 1156-1161.
Crossref
Crossref
Morihisa Saitoh, Jun Kunitomo, Eiji Kimura, Yoji Hayase, Hiromi Kobayashi, Noriko Uchiyama, Tomohiro Kawamoto, Toshimasa Tanaka, Clifford D. Mol, Douglas R. Dougan, Garret S. Textor, Gyorgy P. Snell & Fumio Itoh. (2009) Design, synthesis and structure–activity relationships of 1,3,4-oxadiazole derivatives as novel inhibitors of glycogen synthase kinase-3β. Bioorganic & Medicinal Chemistry 17:5, pages 2017-2029.
Crossref
Crossref
Konstantina VougogiannopoulouYoan FerandinKarima BettayebVassilios MyrianthopoulosOlivier LozachYunzhen FanCarl Hirschie JohnsonProkopios MagiatisAlexios-Leandros SkaltsounisEmmanuel MikrosLaurent Meijer. (2008) Soluble 3′,6-Substituted Indirubins with Enhanced Selectivity toward Glycogen Synthase Kinase -3 Alter Circadian Period. Journal of Medicinal Chemistry 51:20, pages 6421-6431.
Crossref
Crossref
Fei Liu, Zhihou Liang, Jerzy Wegiel, Yu‐Wen Hwang, Khalid Iqbal, Inge Grundke‐Iqbal, Narayan Ramakrishna & Cheng‐Xin Gong. (2008) Overexpression of Dyrk1A contributes to neurofibrillary degeneration in Down syndrome. The FASEB Journal 22:9, pages 3224-3233.
Crossref
Crossref